10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0001104659-20-094673`
Period End Date	20200630
Filing Date	20200813
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	bpth-20200630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 36 Cash Flow Statement 39 Stockholders Equity 23

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$14.41M	USD	Point-in-time
Cash	`Cash`	$20.43M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$1.08M	USD	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$776.00K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.43M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$788.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$21.99M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$16.92M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	3.69M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	3.69M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.03M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	3.69M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	3.69M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.03M	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$762.00K	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$726.00K	USD	Point-in-time
Furniture, fixtures & equipment, net	`PropertyPlantAndEquipmentNet`	$303.00K	USD	Point-in-time
Furniture, fixtures & equipment, net	`PropertyPlantAndEquipmentNet`	$267.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$329.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$367.00K	USD	Point-in-time
Total Assets	`Assets`	$22.66M	USD	Point-in-time
Total Assets	`Assets`	$17.52M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$726.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$486.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$410.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$673.00K	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	$85.00K	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	$89.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.24M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.23M	USD	Point-in-time
Noncurrent lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$284.00K	USD	Point-in-time
Noncurrent lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$330.00K	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.51M	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.57M	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 3,692 and 3,692 shares issued and outstanding, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 3,692 and 3,692 shares issued and outstanding, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$77.71M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$77.42M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-56.34M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-61.70M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$17.91M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$16.01M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$21.09M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$20.14M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$1.22M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$17.93M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$17.52M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$22.66M	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$3.04M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.92M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.03M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.52M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$966.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.09M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.01M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.35M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$4.01M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$2.49M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.04M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$5.39M	USD	2 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-5.39M	USD	2 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-2.49M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-2.04M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-4.01M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$33.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$3.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$41.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$23.00K	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$41.00K	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$33.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$3.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$23.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.46M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.04M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.97M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.36M	USD	2 Qtrs
Net loss per share, basic and diluted (in dollars)	`EarningsPerShareBasicAndDiluted`	$-1.75	USD	2 Qtrs
Net loss per share, basic and diluted (in dollars)	`EarningsPerShareBasicAndDiluted`	$-0.87	USD	1 Quarter
Net loss per share, basic and diluted (in dollars)	`EarningsPerShareBasicAndDiluted`	$-1.45	USD	2 Qtrs
Net loss per share, basic and diluted (in dollars)	`EarningsPerShareBasicAndDiluted`	$-0.55	USD	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.69M	shares	2 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.69M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.27M	shares	2 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.83M	shares	1 Quarter

Cash Flow Statement 39 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-2.46M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.04M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.97M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.36M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$338.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$289.00K	USD	2 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetsAmortization`	$38.00K	USD	2 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetsAmortization`	$56.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$99.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$36.00K	USD	2 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$303.00K	USD	2 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$322.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$42.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$646.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-23.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-328.00K	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$42.00K	USD	2 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$56.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.01M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.22M	USD	2 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$17.00M	USD	Point-in-time
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$19.41M	USD	2 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.50M	USD	Point-in-time
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$900.00K	USD	Point-in-time
Net proceeds from exercise of warrants	`ProceedsFromStockOptionsExercised`	$914.00K	USD	2 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromStockOptionsExercised`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$20.32M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	2 Qtrs
Net (decrease) increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-6.01M	USD	2 Qtrs
Net (decrease) increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$16.10M	USD	2 Qtrs
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.11M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.00M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$14.41M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.43M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.11M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.00M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$14.41M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.43M	USD	Point-in-time

Stockholders Equity 23 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$17.91M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$16.01M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$21.09M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$20.14M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$1.22M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$17.93M	USD	Point-in-time
Issuance of common stock, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$19.41M	USD	2 Qtrs
Exercise of warrants, net of fees	`StockIssueDuringPeriodValueWarrantsExercised`	$914.00K	USD	2 Qtrs
Exercise of warrants, net of fees	`StockIssueDuringPeriodValueWarrantsExercised`	$45.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$338.00K	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$289.00K	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$181.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$119.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.46M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.04M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.97M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.36M	USD	2 Qtrs
Ending Balance	`StockholdersEquity`	$17.91M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$16.01M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$21.09M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$20.14M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$1.22M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$17.93M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.